Concentrix (NASDAQ:CNXC) Upgraded to “Strong-Buy” by Baird R W

Baird R W upgraded shares of Concentrix (NASDAQ:CNXCFree Report) to a strong-buy rating in a report issued on Thursday, Zacks.com reports.

A number of other research analysts have also recently commented on CNXC. Canaccord Genuity Group decreased their target price on Concentrix from $125.00 to $100.00 and set a buy rating for the company in a research report on Thursday, September 26th. Bank of America decreased their price target on Concentrix from $85.00 to $70.00 and set a neutral rating for the company in a report on Thursday, September 26th. Barrington Research dropped their price objective on shares of Concentrix from $84.00 to $70.00 and set an outperform rating on the stock in a research note on Thursday, September 26th. Finally, Robert W. Baird assumed coverage on shares of Concentrix in a research note on Thursday. They issued an outperform rating and a $70.00 target price for the company. One analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of Buy and an average target price of $79.00.

Get Our Latest Stock Analysis on Concentrix

Concentrix Stock Performance

NASDAQ CNXC opened at $52.58 on Thursday. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.57 and a quick ratio of 1.56. Concentrix has a 1-year low of $50.23 and a 1-year high of $106.10. The firm has a market capitalization of $3.42 billion, a P/E ratio of 12.17, a P/E/G ratio of 0.71 and a beta of 0.58. The business’s 50-day simple moving average is $65.82 and its 200-day simple moving average is $63.24.

Concentrix (NASDAQ:CNXCGet Free Report) last released its quarterly earnings data on Wednesday, September 25th. The company reported $2.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.93 by ($0.06). Concentrix had a return on equity of 16.57% and a net margin of 2.18%. The business had revenue of $2.39 billion for the quarter, compared to analysts’ expectations of $2.38 billion. During the same quarter in the prior year, the firm earned $2.54 earnings per share. Concentrix’s quarterly revenue was up 46.2% compared to the same quarter last year. Equities analysts predict that Concentrix will post 10.18 EPS for the current year.

Concentrix Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 5th. Stockholders of record on Friday, October 25th will be paid a $0.333 dividend. This represents a $1.33 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date is Friday, October 25th. This is a positive change from Concentrix’s previous quarterly dividend of $0.30. Concentrix’s dividend payout ratio is 28.01%.

Insider Buying and Selling

In other Concentrix news, CEO Christopher A. Caldwell sold 9,823 shares of the stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $52.70, for a total transaction of $517,672.10. Following the transaction, the chief executive officer now owns 241,841 shares of the company’s stock, valued at $12,745,020.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CEO Christopher A. Caldwell sold 9,823 shares of the firm’s stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $52.70, for a total value of $517,672.10. Following the transaction, the chief executive officer now directly owns 241,841 shares in the company, valued at approximately $12,745,020.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Cormac J. Twomey sold 400 shares of the business’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $74.63, for a total transaction of $29,852.00. Following the sale, the executive vice president now directly owns 29,327 shares of the company’s stock, valued at approximately $2,188,674.01. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 12,167 shares of company stock worth $653,747. Corporate insiders own 3.00% of the company’s stock.

Institutional Trading of Concentrix

Several hedge funds have recently made changes to their positions in the stock. Groupe Bruxelles Lambert acquired a new stake in shares of Concentrix in the fourth quarter valued at approximately $861,662,000. Vanguard Group Inc. raised its stake in Concentrix by 23.9% during the 4th quarter. Vanguard Group Inc. now owns 5,363,893 shares of the company’s stock valued at $526,788,000 after acquiring an additional 1,034,546 shares in the last quarter. 1832 Asset Management L.P. acquired a new position in Concentrix during the 2nd quarter worth $62,738,000. Pzena Investment Management LLC grew its stake in shares of Concentrix by 246.3% in the first quarter. Pzena Investment Management LLC now owns 1,013,208 shares of the company’s stock worth $67,095,000 after purchasing an additional 720,616 shares in the last quarter. Finally, Impactive Capital LP increased its holdings in shares of Concentrix by 13.0% during the first quarter. Impactive Capital LP now owns 3,846,370 shares of the company’s stock valued at $254,707,000 after purchasing an additional 443,045 shares during the period. Institutional investors own 90.34% of the company’s stock.

About Concentrix

(Get Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Featured Stories

Analyst Recommendations for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.